{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:39:45Z","timestamp":1782185985524,"version":"3.54.5"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"suppl_2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,15]]},"DOI":"10.1093\/cid\/cit300","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T23:20:11Z","timestamp":1374708011000},"page":"S32-S38","source":"Crossref","is-referenced-by-count":131,"title":["Injection Drug Use and Hepatitis C Virus Infection in Young Adult Injectors: Using Evidence to Inform Comprehensive Prevention"],"prefix":"10.1093","volume":"57","author":[{"given":"Kimberly","family":"Page","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan D.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,8,15]]},"reference":[{"key":"key\n\t\t\t\t20171013233317_CIT300C1","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection","volume":"200","author":"Page","year":"2009","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013233317_CIT300C2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1086\/649783","article-title":"Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities","volume":"201","author":"Hagan","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013233317_CIT300C3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/infdis\/jiq112","article-title":"Changes in blood-borne infection risk among injection drug users","volume":"203","author":"Mehta","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013233317_CIT300C4","first-page":"358","article-title":"Notes from the field: hepatitis C virus infections among young adults\u2014rural Wisconsin, 2010","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171013233317_CIT300C5","first-page":"537","article-title":"Hepatitis C virus infection among adolescents and young adults: Massachusetts, 2002\u20132009","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171013233317_CIT300C6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/003335491012500116","article-title":"Viral hepatitis and injection drug use in Appalachian Kentucky: a survey of rural health department clients","volume":"125","author":"Christian","year":"2010","journal-title":"Public Health Rep"},{"key":"key\n\t\t\t\t20171013233317_CIT300C7","first-page":"517","article-title":"Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users\u2014New York, November 2004\u2013April 2007","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171013233317_CIT300C8","article-title":"Results from the 2011 National Survey on Drug Use and Health: summary of national findings","author":"Substance Abuse and Mental Health Services Administration","year":"2012"},{"key":"key\n\t\t\t\t20171013233317_CIT300C9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1360-0443.2012.03803.x","article-title":"The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users","volume":"107","author":"Bruneau","year":"2012","journal-title":"Addiction"},{"key":"key\n\t\t\t\t20171013233317_CIT300C10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/archinte.167.2.166","article-title":"Injection drug users in the United States, 1979\u20132002: an aging population","volume":"167","author":"Armstrong","year":"2007","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20171013233317_CIT300C11","first-page":"133","article-title":"HIV infection and HIV-associated behaviors among injecting drug users\u201420 cities, United States, 2009","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171013233317_CIT300C12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/aje\/kwn237","article-title":"Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place","volume":"168","author":"Hagan","year":"2008","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20171013233317_CIT300C13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171013233317_CIT300C14","first-page":"615","article-title":"Determination of risk of infection with blood-borne pathogens following a needlestick injury in hospital workers","volume":"52","author":"Wicker","year":"2008","journal-title":"Ann Occup Hyg"},{"key":"key\n\t\t\t\t20171013233317_CIT300C15","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/656212","article-title":"Survival of hepatitis C virus in syringes: implication for transmission among injection drug users","volume":"202","author":"Paintsil","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013233317_CIT300C16","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/infdis\/jir535","article-title":"Inactivation and survival of hepatitis C virus on inanimate surfaces","volume":"204","author":"Doerrbecker","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013233317_CIT300C17","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/345554","article-title":"Hepatitis C virus seroconversion among young injection drug users: relationships and risks","volume":"186","author":"Hahn","year":"2002","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013233317_CIT300C18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1360-0443.2011.03765.x","article-title":"Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment","volume":"107","author":"Pouget","year":"2011","journal-title":"Addiction"},{"key":"key\n\t\t\t\t20171013233317_CIT300C19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013233317_CIT300C20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7326\/0003-4819-140-6-200403160-00014","article-title":"Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force","volume":"140","author":"Chou","year":"2004","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171013233317_CIT300C21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.drugalcdep.2009.05.022","article-title":"Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco","volume":"105","author":"Tsui","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"key\n\t\t\t\t20171013233317_CIT300C22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/342063","article-title":"Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland","volume":"35","author":"Ompad","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013233317_CIT300C23","first-page":"52","article-title":"The effects of HIV counseling and testing on risk-related practices and help-seeking behavior","volume":"9","author":"Wolitski","year":"1997","journal-title":"AIDS Educ Prev"},{"key":"key\n\t\t\t\t20171013233317_CIT300C24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/JCM.01229-07","article-title":"Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates","volume":"46","author":"Page-Shafer","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171013233317_CIT300C25","first-page":"26","article-title":"Acceptability and implications of rapid HCV test among high risk young injection drug users","author":"Briceno","year":"2013"},{"key":"key\n\t\t\t\t20171013233317_CIT300C26","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1360-0443.2006.01543.x","article-title":"Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia","volume":"101","author":"Maher","year":"2006","journal-title":"Addiction"},{"key":"key\n\t\t\t\t20171013233317_CIT300C27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10654-006-9089-7","article-title":"Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users","volume":"22","author":"van den Berg","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"key\n\t\t\t\t20171013233317_CIT300C28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jurban\/jtg137","article-title":"Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study)","volume":"80","author":"Evans","year":"2003","journal-title":"J Urban Health"},{"key":"key\n\t\t\t\t20171013233317_CIT300C29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1015441030030","article-title":"Sex-specific differences in circumstances of initiation into injecting-drug use among young adult Latinos in Harlem, New York. City","volume":"6","author":"Diaz","year":"2002","journal-title":"AIDS Behav"},{"key":"key\n\t\t\t\t20171013233317_CIT300C30","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1081\/JA-100108439","article-title":"Social factors related to syringe sharing among injecting partners: a focus on gender","volume":"36","author":"Sherman","year":"2001","journal-title":"Subst Use Misuse"},{"key":"key\n\t\t\t\t20171013233317_CIT300C31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1360-0443.2010.02949.x","article-title":"Hepatitis C virus risk behaviors within the partnerships of young injecting drug users","volume":"105","author":"Hahn","year":"2010","journal-title":"Addiction"},{"key":"key\n\t\t\t\t20171013233317_CIT300C32","article-title":"Risk profiles of injecting partnerships: correlates of receptive syringe and cooker sharing among a cohort of young injection drug users in San Francisco, CA","author":"Morris"},{"key":"key\n\t\t\t\t20171013233317_CIT300C33","first-page":"286207","article-title":"Effectiveness of couple-based HIV counseling and testing for women substance users and their primary male partners: a randomized trial","author":"McMahon","year":"2013","journal-title":"Adv Prev Med"},{"key":"key\n\t\t\t\t20171013233317_CIT300C34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2005.11.007","article-title":"Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988\u20132000","volume":"83","author":"Shah","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"key\n\t\t\t\t20171013233317_CIT300C35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/aje\/kwp416","article-title":"Neighborhood poverty and injection cessation in a sample of injection drug users","volume":"171","author":"Nandi","year":"2010","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20171013233317_CIT300C36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.drugalcdep.2008.12.007","article-title":"Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study)","volume":"101","author":"Evans","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"key\n\t\t\t\t20171013233317_CIT300C37","first-page":"115","article-title":"Harm reduction among injection drug users\u2014evidence of effectiveness","volume-title":"Harm reduction\u2014evidence, impacts and challenges","author":"Rhodes","year":"2010"},{"key":"key\n\t\t\t\t20171013233317_CIT300C38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11920-009-0054-5","article-title":"Treatment of opioid-dependent adolescents and young adults with buprenorphine","volume":"11","author":"Subramaniam","year":"2009","journal-title":"Curr Psychiatry Rep"},{"key":"key\n\t\t\t\t20171013233317_CIT300C39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/QAI.0b013e3181a2539a","article-title":"The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis","volume":"51","author":"Kwon","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"suppl 1","key":"key\n\t\t\t\t20171013233317_CIT300C40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1478-3231.2011.02699.x","article-title":"Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow","volume":"32","author":"Asselah","year":"2012","journal-title":"Liver Int"},{"key":"key\n\t\t\t\t20171013233317_CIT300C41","doi-asserted-by":"crossref","first-page":"e22309","DOI":"10.1371\/journal.pone.0022309","article-title":"Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug users","volume":"6","author":"Martin","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171013233317_CIT300C42","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.drugalcdep.2010.03.006","article-title":"Optimal targeting of hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs","volume":"110","author":"Zeiler","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"key\n\t\t\t\t20171013233317_CIT300C43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.epidem.2008.10.002","article-title":"Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users","volume":"1","author":"Hahn","year":"2009","journal-title":"Epidemics"},{"key":"key\n\t\t\t\t20171013233317_CIT300C44","doi-asserted-by":"crossref","first-page":"115ra1","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20171013233317_CIT300C45","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1016\/j.vaccine.2010.08.085","article-title":"Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities","volume":"28","author":"Maher","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171013233317_CIT300C46","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users","volume":"102","author":"Van Den Berg","year":"2007","journal-title":"Addiction"},{"key":"key\n\t\t\t\t20171013233317_CIT300C47","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence","volume":"106","author":"Turner","year":"2011","journal-title":"Addiction"},{"key":"key\n\t\t\t\t20171013233317_CIT300C48","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/j.1360-0443.2012.03932.x","article-title":"Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings","volume":"107","author":"Vickerman","year":"2012","journal-title":"Addiction"},{"key":"key\n\t\t\t\t20171013233317_CIT300C49","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2105\/AJPH.90.9.1387","article-title":"Needle exchange, pragmatism, and moralism","volume":"90","author":"Coutinho","year":"2000","journal-title":"Am J Public Health"},{"key":"key\n\t\t\t\t20171013233317_CIT300C50","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/COH.0b013e32835369ad","article-title":"Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention","volume":"7","author":"Strathdee","year":"2012","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/57\/suppl_2\/S32\/20911946\/cit300.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T03:33:24Z","timestamp":1507952004000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/57\/suppl_2\/S32\/397297\/Injection-Drug-Use-and-Hepatitis-C-Virus-Infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,15]]},"references-count":50,"journal-issue":{"issue":"suppl_2","published-online":{"date-parts":[[2013,8,15]]},"published-print":{"date-parts":[[2013,8,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cit300","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,8,15]]},"published":{"date-parts":[[2013,8,15]]}}}